Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-1,100
Closed -$1K 4809
2022
Q4
$1K Sell
1,100
-3,300
-75% -$4.66K ﹤0.01% 4188
2022
Q3
$18K Sell
4,400
-200
-4% -$690 ﹤0.01% 2702
2022
Q2
$14K Sell
4,600
-400
-8% -$1.49K ﹤0.01% 2977
2022
Q1
$9K Buy
5,000
+2,200
+79% +$11.1K ﹤0.01% 3722
2021
Q4
$7K Sell
2,800
-200
-7% -$1.37K ﹤0.01% 3995
2021
Q3
$7K Sell
3,000
-5,100
-63% -$42K ﹤0.01% 4258
2021
Q2
$9K Buy
8,100
+2,300
+40% +$16.1K ﹤0.01% 4016
2021
Q1
$13K Buy
5,800
+3,200
+123% +$24.6K ﹤0.01% 3596
2020
Q4
$6K Sell
2,600
-34,900
-93% -$222K ﹤0.01% 3572
2020
Q3
$115K Buy
+37,500
New +$334K 0.01% 1236

Other funds holding VXRT

Cutler Group's VXRT Position: Q1 2023 in Review

Cutler Group sold out of Vaxart (VXRT) in Q1 2023, closing a stake of 500 shares.

Cutler Group first reported a position in VXRT in Q4 2015 and held it in 16 quarters. The position peaked at $148K in Q3 2020. 109 funds tracked by Wall St. Rank hold VXRT as of Q1 2023.

  • Cutler Group reported no remaining Vaxart position as of Q1 2023 after selling out during the quarter.
  • Cutler Group sold 500 Vaxart shares in Q1 2023.
  • Cutler Group first reported a position in Vaxart in Q4 2015 and held it in 16 quarters.
  • Cutler Group's Vaxart position peaked at $148K in Q3 2020.
  • 109 funds tracked by Wall St. Rank held Vaxart as of Q1 2023.

Based on Cutler Group's 13F filing for Q1 2023, filed 1 May 2023.